GB1296561A - - Google Patents
Info
- Publication number
- GB1296561A GB1296561A GB1296561DA GB1296561A GB 1296561 A GB1296561 A GB 1296561A GB 1296561D A GB1296561D A GB 1296561DA GB 1296561 A GB1296561 A GB 1296561A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- alkoxy
- phenyl
- antiviral
- jan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- -1 α-naphthyl Chemical group 0.000 abstract 3
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 abstract 1
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79474969A | 1969-01-28 | 1969-01-28 | |
| US79475669A | 1969-01-28 | 1969-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1296561A true GB1296561A (en:Method) | 1972-11-15 |
Family
ID=27121543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1296561D Expired GB1296561A (en:Method) | 1969-01-28 | 1970-01-28 |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE744970A (en:Method) |
| CY (1) | CY777A (en:Method) |
| DE (1) | DE2003841C3 (en:Method) |
| FR (1) | FR2034500B1 (en:Method) |
| GB (1) | GB1296561A (en:Method) |
| MY (1) | MY7500001A (en:Method) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4046770A (en) | 1974-08-30 | 1977-09-06 | Eli Lilly And Company | N-(6-acyloxybenzothiazol-2-yl)-N'-phenyl (or substituted phenyl)ureas |
| US6380232B1 (en) * | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6906091B2 (en) | 1999-08-13 | 2005-06-14 | Uaf Technologies And Research, Llc | Method of cancer treatment |
| US6930121B2 (en) | 2000-09-26 | 2005-08-16 | Uaf Technologies And Research, Llc | Compounds and methods for use thereof in the treatment of viral infections |
| US6984654B2 (en) | 1997-05-16 | 2006-01-10 | Uaf Technologies And Research, Llc | Cancer treatments and pharmaceutical compositions therefor |
| WO2006013054A1 (en) * | 2004-08-05 | 2006-02-09 | F. Hoffmann-La Roche Ag | Substituted n-acyl-2-aminothiazoles |
| US20150344449A1 (en) * | 2012-12-21 | 2015-12-03 | Janssen R&D Ireland | Antibacterial compounds |
| EP2945625A4 (en) * | 2013-01-15 | 2016-09-14 | Kineta Inc | ANTIVIRAL CONNECTIONS |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| BE792606A (fr) * | 1972-01-06 | 1973-03-30 | Ferlux | Nouveaux semicarbazides et thiosemicarbazides et leur preparation |
| FR2186238A1 (en) * | 1972-05-05 | 1974-01-11 | Ferlux | N-2-imidazolinyl-N'-acylhydrazides - with analgesic hypotensive and cardiac stimulant activity |
| US3932434A (en) * | 1974-08-30 | 1976-01-13 | Eli Lilly And Company | N-2-(6-hydroxybenzothiazolyl)-N'-phenyl (or substituted phenyl) ureas |
| AU6517698A (en) | 1997-03-25 | 1998-10-20 | Kowa Company Ltd. | Novel anilide compounds and drugs containing the same |
-
1970
- 1970-01-27 BE BE744970D patent/BE744970A/xx unknown
- 1970-01-28 FR FR7002955A patent/FR2034500B1/fr not_active Expired
- 1970-01-28 CY CY77770A patent/CY777A/xx unknown
- 1970-01-28 GB GB1296561D patent/GB1296561A/en not_active Expired
- 1970-01-28 DE DE19702003841 patent/DE2003841C3/de not_active Expired
-
1975
- 1975-12-30 MY MY7500001A patent/MY7500001A/xx unknown
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4046770A (en) | 1974-08-30 | 1977-09-06 | Eli Lilly And Company | N-(6-acyloxybenzothiazol-2-yl)-N'-phenyl (or substituted phenyl)ureas |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6653335B2 (en) | 1995-04-12 | 2003-11-25 | University Of Arizona Foundationa | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6984654B2 (en) | 1997-05-16 | 2006-01-10 | Uaf Technologies And Research, Llc | Cancer treatments and pharmaceutical compositions therefor |
| US6906091B2 (en) | 1999-08-13 | 2005-06-14 | Uaf Technologies And Research, Llc | Method of cancer treatment |
| US6930121B2 (en) | 2000-09-26 | 2005-08-16 | Uaf Technologies And Research, Llc | Compounds and methods for use thereof in the treatment of viral infections |
| US6720349B2 (en) | 2000-09-26 | 2004-04-13 | Uaf Technologies And Research, Llc | Compounds for use in the treatment of cancer or viral infections |
| US6916836B2 (en) | 2000-09-26 | 2005-07-12 | Uaf Technologies And Research, Llc | Compounds and methods for use thereof in the treatment of viral infections |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) * | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| WO2006013054A1 (en) * | 2004-08-05 | 2006-02-09 | F. Hoffmann-La Roche Ag | Substituted n-acyl-2-aminothiazoles |
| US7407977B2 (en) | 2004-08-05 | 2008-08-05 | Hoffman-La Roche Inc. | Substituted N-acyl-2-aminothiazoles |
| RU2371438C2 (ru) * | 2004-08-05 | 2009-10-27 | Ф.Хоффманн-Ля Рош Аг | Замещенные 2-ацил-2-аминотиазолы |
| US20150344449A1 (en) * | 2012-12-21 | 2015-12-03 | Janssen R&D Ireland | Antibacterial compounds |
| US9428474B2 (en) * | 2012-12-21 | 2016-08-30 | Janssen Sciences Ireland Uc | Antibacterial compounds |
| US9951032B2 (en) * | 2012-12-21 | 2018-04-24 | Janssen Sciences Ireland Uc | Antibacterial compounds |
| EP2945625A4 (en) * | 2013-01-15 | 2016-09-14 | Kineta Inc | ANTIVIRAL CONNECTIONS |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2003841C3 (de) | 1974-04-11 |
| CY777A (en) | 1975-03-01 |
| MY7500001A (en) | 1975-12-31 |
| DE2003841A1 (de) | 1970-07-30 |
| BE744970A (fr) | 1970-07-27 |
| FR2034500B1 (en:Method) | 1974-06-14 |
| DE2003841B2 (de) | 1973-09-06 |
| FR2034500A1 (en:Method) | 1970-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1296561A (en:Method) | ||
| GB1321509A (en) | Azepine derivatives | |
| GB1155937A (en) | Novel Oxazolidinones | |
| GB1171156A (en) | Improvements in or relating to Cycloalkane Derivatives and the Manufacture thereof | |
| GB1461032A (en) | Erthromycylamine derivatives | |
| GB1153424A (en) | Pharmaceutical Compositions | |
| GB1342828A (en) | Pyrimidinyl-piperazines and processes for their preparation | |
| GB1198459A (en) | Substituted 2-Amino and 2-Nitrobenzamides and preparation thereof | |
| GB1407856A (en) | Anti-inflammatory thiazole compositions and methods for using same | |
| GB1530770A (en) | 2,4-imidazolidinedione derivatives and preparation thereo | |
| GB1251147A (en:Method) | ||
| GB1291442A (en) | Adamantylamino-5,8-dihydronaphthyloxy-propanols and related compounds | |
| GB1450801A (en) | Pyridinecarboxamide sulphonylurea hypoglycemic agents | |
| GB1290381A (en:Method) | ||
| FR2222375A1 (en) | 5-Substd guanidino barbituric acids - intermediates prepd from a cyanamide and a uramil | |
| GB1290841A (en:Method) | ||
| HUP9801228A2 (hu) | Szubsztituált benzamidinek és az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| GB1353486A (en) | Benzodiazepine derivatives | |
| GB1138315A (en) | 2-amino-benzylamines | |
| GB1158632A (en) | New Tri- and Tetrathiophosphate Esters | |
| GB1468079A (en) | Ethanolamine derivatives | |
| ES449689A1 (es) | Procedimiento para la preparacion de n (fenileter sustitui- das bencil) alcanodiaminas. | |
| GB1406307A (en) | Production of benzylpyrimidines | |
| GB1164058A (en) | Novel Sulphanilamides and a process for the manufacture thereof | |
| GB1198853A (en) | Adamante Derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |